Style | Citing Format |
---|---|
MLA | Sharafian S, et al.. "The Efficacy of a New Protocol of Oral Immunotherapy to Wheat for Desensitization and Induction of Tolerance." Iranian Journal of Allergy# Asthma and Immunology, vol. 21, no. 3, 2022, pp. 232-240. |
APA | Sharafian S, Amirzargar A, Gharagozlou M, Parvaneh N, Shariat M, Tavakol M, Movahedi M (2022). The Efficacy of a New Protocol of Oral Immunotherapy to Wheat for Desensitization and Induction of Tolerance. Iranian Journal of Allergy# Asthma and Immunology, 21(3), 232-240. |
Chicago | Sharafian S, Amirzargar A, Gharagozlou M, Parvaneh N, Shariat M, Tavakol M, Movahedi M. "The Efficacy of a New Protocol of Oral Immunotherapy to Wheat for Desensitization and Induction of Tolerance." Iranian Journal of Allergy# Asthma and Immunology 21, no. 3 (2022): 232-240. |
Harvard | Sharafian S et al. (2022) 'The Efficacy of a New Protocol of Oral Immunotherapy to Wheat for Desensitization and Induction of Tolerance', Iranian Journal of Allergy# Asthma and Immunology, 21(3), pp. 232-240. |
Vancouver | Sharafian S, Amirzargar A, Gharagozlou M, Parvaneh N, Shariat M, Tavakol M, et al.. The Efficacy of a New Protocol of Oral Immunotherapy to Wheat for Desensitization and Induction of Tolerance. Iranian Journal of Allergy# Asthma and Immunology. 2022;21(3):232-240. |
BibTex | @article{ author = {Sharafian S and Amirzargar A and Gharagozlou M and Parvaneh N and Shariat M and Tavakol M and Movahedi M}, title = {The Efficacy of a New Protocol of Oral Immunotherapy to Wheat for Desensitization and Induction of Tolerance}, journal = {Iranian Journal of Allergy# Asthma and Immunology}, volume = {21}, number = {3}, pages = {232-240}, year = {2022} } |
RIS | TY - JOUR AU - Sharafian S AU - Amirzargar A AU - Gharagozlou M AU - Parvaneh N AU - Shariat M AU - Tavakol M AU - Movahedi M TI - The Efficacy of a New Protocol of Oral Immunotherapy to Wheat for Desensitization and Induction of Tolerance JO - Iranian Journal of Allergy# Asthma and Immunology VL - 21 IS - 3 SP - 232 EP - 240 PY - 2022 ER - |